Organigram Global (OGI) Total Current Liabilities (2018 - 2025)
Organigram Global (OGI) posted quarterly Total Current Liabilities of $91.7 million for Q3 2025, up 134.53% year-over-year from $39.1 million in Q3 2024, and up 134.53% quarter-over-quarter from $39.1 million in Q3 2024.
Organigram Global (OGI) Total Current Liabilities (2018 - 2025) Analysis & Trends
Organigram Global (OGI) has reported Total Current Liabilities for 8 consecutive years, with $91.7 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Total Current Liabilities rose 134.53% year-over-year to $91.7 million; the TTM figure through Sep 2025 stood at $91.7 million (up 134.53% YoY), while the FY2025 annual figure was $91.7 million, up 134.53% from the prior year.
- Total Current Liabilities advanced to $91.7 million in Q3 2025 per OGI's latest filing, from $39.1 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $91.7 million in Q3 2025 and bottomed at $16.7 million in Q3 2023.
- Historically, Total Current Liabilities has averaged $38.6 million across 5 years, with a median of $30.1 million in 2021.
- Annual changes were most pronounced in 2021 — Total Current Liabilities tumbled 82.21% — and 2025, when it soared 134.53%.
- Organigram Global's Total Current Liabilities stood at $21.1 million in 2021, then jumped by 103.17% to $42.9 million in 2022, then tumbled by 61.02% to $16.7 million in 2023, then surged by 133.61% to $39.1 million in 2024, then jumped by 134.53% to $91.7 million in 2025.
- Business Quant data shows OGI's Total Current Liabilities at $91.7 million in Q3 2025, $39.1 million in Q3 2024, and $16.7 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 1.79 Bn |
| 10 | Organigram Global | 150.66 Mn | 150.54 Mn | 28.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 91.67 Mn |
| Sep 30, 2024 | 39.09 Mn |
| Sep 30, 2023 | 16.73 Mn |
| Aug 31, 2022 | 42.93 Mn |
| Aug 31, 2021 | 21.13 Mn |
| Feb 28, 2021 | 19.86 Mn |
| Nov 30, 2020 | 78.26 Mn |
| Aug 31, 2020 | 21.64 Mn |
| May 31, 2020 | 22.57 Mn |
| Feb 29, 2020 | 111.58 Mn |
| Aug 31, 2019 | 33.18 Mn |
| May 31, 2019 | 25.67 Mn |
| Aug 31, 2018 | 8.59 Mn |